Skip to main content
Search
Main content
Image showing microglia stained in green

Qiu Lab

Unravelling microglial signalling in health and disease

Techniques

Bioinformatics, Drug screening, Flow cytometry, Mass spec-based proteomics

Key details

Hugh Robson Building, University of Edinburgh
Dr Jing Qiu

Preventing inflammation and damage in neurodegeneration

Dr Jing Qiu studies how to protect the brain from inflammation and damage in diseases like Alzheimer’s and vascular dementia.

In healthy brains, immune cells called microglia support and protect brain function. However, in neurodegenerative diseases, these cells can change and start causing harm, leading to inflammation and damage. The Qiu Lab is working to find ways to prevent this harmful shift, helping microglia keep their normal, protective roles.

The lab also investigates the blood-brain barrier, a vital shield that keeps harmful substances out of the brain. When this barrier is weakened, inflammation can develop and worsen brain conditions. Jing's research looks at ways to strengthen the blood-brain barrier, especially after infections or in long-term diseases, to prevent brain damage.

Through this work, the lab aims to find new treatments to slow or prevent dementia and other neurodegenerative diseases.

Dr Jing Qiu

Dr Jing Qiu is an Emerging Leader at the UK DRI at Edinburgh. Find out more about her career and expertise on her profile page.

Jing Qiu

Research summary

Image showing microglia stained in green

Microglia stained in green Credit: Dr Jing Qiu

Identifying novel strategies to modulate microglial phenotype and neuroinflammation

Dr Jing Qiu’s lab focuses on two main research areas to address neuroinflammation and blood-brain barrier (BBB) dysfunction in neurodegenerative diseases.

Programme 1 aims to identify therapeutic strategies to prevent harmful transformations in microglia, the brain’s immune cells, which play a significant role in the progression of neurodegenerative diseases. While microglia perform essential maintenance functions in a healthy brain, they can convert into a disease-associated subtype (MgND) during infection or in neurodegeneration. This harmful subtype is linked to inflammation, synapse damage, vascular dysfunction, and an overactive inflammatory response. Currently, no therapies exist to control this transformation. Dr Qiu’s lab is investigating methods to prevent this detrimental shift, enabling microglia to maintain their protective functions and respond properly to inflammation. This work could lead to novel approaches to reduce neuroinflammation in conditions like Alzheimer’s and Parkinson’s disease.

Programme 2 explores the role of blood-brain barrier integrity in neuroinflammation, especially following systemic infections or in diseases like vascular dementia. The BBB is crucial for protecting the brain, regulating the passage of nutrients and preventing harmful molecules from entering. When the BBB is compromised, neuroinflammation can result, exacerbating neurological conditions. Dr Qiu’s team is examining how modulating trans-BBB signaling can preserve BBB function, using both in vitro and in vivo models. This research seeks to prevent endothelial cell dysfunction, thereby reducing inflammation and protecting brain health in both acute and chronic settings.

Through these programs, Dr Qiu’s lab is advancing our understanding of neuroinflammation and identifying potential interventions to mitigate brain damage in neurodegenerative diseases.

Key publications

Vacancies

There are currently no vacancies available.

Lab members

  • Tom Leah (Technician)
  • Haoyu (Janice) Zou (PhD Student)
  • Allen Shaw (MSc student)
  • Zhuochun Huang (PhD Student)

Collaborators

Lab funders

Thank you to all those who support the Qiu Lab!